Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 3Other hematologic neoplasm 2Gynecologic 2Genitourinary 2Head & Neck 1CNS 1

Conditions

Lung Neoplasms 3Prostatic Neoplasms 1Neoplasms 1Disease 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Diagnosis × Thoracic × Clear all
NCT06270992 2024-02-21

Oral Microbiome Diagnostics of Lung Cancer

TC Erciyes University

Unknown
676 enrolled
Thoracic

Lung Neoplasms

NCT00581503 2022-10-20

Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer

University of California, Irvine

Withdrawn
GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

NCT03645018 2018-09-14

SOS2

Ospedale Santa Croce-Carle Cuneo

Phase 3 Completed
1,341 enrolled
Thoracic

Disease, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡